X

XeroThera Europe (Private limited company)

BE 0697.932.717 Active ●Avenue Hippocrate 5, 4000 Liège

XeroThera Europe is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0697.932.717. It was founded on 14-06-2018. Its registered office is in Liège. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 646 920 and a loss of € 36 329. These accounts report 2 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 15-10-2026.

Company information

Status
Active
Enterprise number
BE 0697.932.717
VAT registered
Yes
Founded
14-06-2018
Latest accounts
2025
Employees
2 FTE
Region
Wallonia
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Avenue Hippocrate 5, 4000 Liège
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21100 Fabrication de produits pharmaceutiques de base
21209 Fabrication d'autres produits pharmaceutiques
72101 Recherche-développement en biotechnologie

Key figures of XeroThera Europe

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -36 329+69 %€ -117 261-69 %€ -69 296-4 268 %€ -1 586
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 646 920+275 %€ 172 325-40 %€ 289 586€ -119
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 820 359+53 %€ 534 885-13 %€ 614 289+182 %€ 217 574
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 196 870+181 %€ 70 023€ -59 088-7 189 %€ -811
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
2+11 %1.8+80 %1-

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Liège.

CompanyTown
LABORATOIRES LOHMANN & RAUSCHER 4000 Liège
Jenatzy Engineering 4000 Liège
CREATIQUE 4000 Liège
Smash 51 4000 Liège
Mithra Pharmaceuticals 4000 Liège
ZENOBE 4000 Liège
THERMIVENT II 4000 Liège
SOFINTRA 4000 Liège
Looking for more information about XeroThera Europe?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is XeroThera Europe still active? Yes. The Crossroads Bank for Enterprises lists XeroThera Europe as active.

What is the VAT number of XeroThera Europe? The VAT number of XeroThera Europe is BE 0697.932.717.

When was XeroThera Europe founded? XeroThera Europe was founded on 14-06-2018.

What is the address of XeroThera Europe? The current registered office of XeroThera Europe is Avenue Hippocrate 5, 4000 Liège.

When did XeroThera Europe last file annual accounts? The latest annual accounts of XeroThera Europe were filed on 14-08-2026.

Does XeroThera Europe file its annual accounts on time? Yes. XeroThera Europe filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does XeroThera Europe have? XeroThera Europe employs 2 full-time equivalents according to its most recent annual accounts.

Is XeroThera Europe financially healthy? Addrly gives XeroThera Europe a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is XeroThera Europe profitable? The annual accounts of XeroThera Europe for 2025 show a loss of € 36 329.

What is the equity of XeroThera Europe? The equity of XeroThera Europe was € 646 920 at the close of the 2025 financial year.

Who are the directors of XeroThera Europe? The annual accounts of XeroThera Europe record 1 mandate. The name, role and dates are visible with a free account.

Can XeroThera Europe receive Peppol e-invoices? Yes. XeroThera Europe is registered on the Peppol network and can receive structured electronic invoices.

What does XeroThera Europe do? The main activity of XeroThera Europe is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data